Tandem Diabetes Care Inc - Asset Resilience Ratio

Latest as of March 2026: 33.89%

Tandem Diabetes Care Inc (TNDM) has an Asset Resilience Ratio of 33.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tandem Diabetes Care Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$390.93 Million

Cash + Short-term Investments

Total Assets

$1.15 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Tandem Diabetes Care Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Tandem Diabetes Care Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tandem Diabetes Care Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tandem Diabetes Care Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$390.93 Million	33.89%
Total Liquid Assets	$390.93 Million	33.89%

Asset Resilience Insights

Very High Liquidity: Tandem Diabetes Care Inc maintains exceptional liquid asset reserves at 33.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Tandem Diabetes Care Inc Industry Peers by Asset Resilience Ratio

Compare Tandem Diabetes Care Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	6.89%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%

Annual Asset Resilience Ratio for Tandem Diabetes Care Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Tandem Diabetes Care Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.93%	$202.03 Million	$881.11 Million	-15.21pp
2024-12-31	38.14%	$369.10 Million	$967.66 Million	-4.79pp
2023-12-31	42.94%	$409.04 Million	$952.66 Million	+0.73pp
2022-12-31	42.21%	$444.38 Million	$1.05 Billion	-18.84pp
2021-12-31	61.05%	$552.63 Million	$905.14 Million	+6.57pp
2020-12-31	54.48%	$390.32 Million	$716.41 Million	+16.07pp
2019-12-31	38.42%	$125.28 Million	$326.11 Million	-3.85pp
2018-12-31	42.27%	$87.20 Million	$206.29 Million	+41.77pp
2017-12-31	0.50%	$479.00K	$95.35 Million	-7.38pp
2016-12-31	7.88%	$8.86 Million	$112.39 Million	-14.51pp
2015-12-31	22.39%	$28.02 Million	$125.12 Million	-11.52pp
2014-12-31	33.91%	$36.11 Million	$106.46 Million	+30.77pp
2013-12-31	3.14%	$5.10 Million	$162.22 Million	+3.02pp
2012-12-31	0.13%	$50.00K	$39.82 Million	-0.23pp
2011-12-31	0.36%	$50.00K	$13.98 Million	--

pp = percentage points

About Tandem Diabetes Care Inc

NASDAQ:TNDM USA Medical Devices

Market Cap

$1.06 Billion

Market Cap Rank

#8843 Global

#2455 in USA

Share Price

$15.40

Change (1 day)

-7.73%

52-Week Range

$10.12 - $28.26

All Time High

$153.21